Efficacy and Safety of SHR-3167 and Insulin Glargine in Type 2 Diabetes Subjects

Clinical trial NCT06688123 · COMPLETED

Trial details

NCT number: NCT06688123
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2025-01-08
Primary completion: 2026-04-22
Enrollment: 275

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.